Tag: biopsy

A new paper on PSA screening for prostate cancer (PCa) begins by pointing out that screening reduces PCa deaths; however, PSA followed by immediate biopsy increases cases of low-risk patients who have overly aggressive treatments that leave them with impaired urinary or sexual function—up to 12 years or more![i] The authors propose more refined screening keep reading

Okay, folks, this is BIG NEWS! A research study out of the esteemed Johns Hopkins University School of Medicine and two other academic centers may be the first of its kind to definitively connect healthy diet with reining in prostate cancer (PCa). Specifically, the study population was done with PCa patients currently on Active Surveillance keep reading

The use of 2 parameters of imaging sequences is called biparametric MRI (bpMRI) – and new research shows it could make MRI widely available as a better screening tool than the PSA test which can lead to overdiagnosis and overtreatment. Now there’s an exciting boost to the speed and accuracy of bpMRI: Deep Learning (DL), a branch of Artificial Intelligence (AI). keep reading

If you’re a real estate developer planning to build a new house, you start with the groundwork—literally. Before you start excavating, you have analysts determine the basics: the type of soil, the water table, and any flood risk. You want to know the important foundation factors that help predict the future stability of the construction. keep reading

New research reveals that liquid biomarkers—measured through simple blood and urine tests—are revolutionizing prostate cancer care. By detecting disease progression early, they help prevent overtreatment and ensure timely, targeted therapies for metastatic cases. Discover how these cutting-edge tests are reshaping prostate cancer care. keep reading

A groundbreaking study reveals how artificial intelligence outperforms traditional methods in prostate cancer risk stratification. By leveraging deep learning and digital biopsy data, AI enhances accuracy, reduces errors, and improves treatment planning for better outcomes. Learn how this innovative technology is transforming prostate cancer diagnosis and care. keep reading

A groundbreaking European study highlights the benefits of adding MRI to PSA screening for prostate cancer. By improving detection of significant cancers and reducing unnecessary biopsies, this approach offers a more accurate, cost-effective pathway for diagnosis. Discover how this research is transforming prostate health and diagnosis standards worldwide. keep reading

Want to avoid a biopsy after an abnormal PSA test? A new study shows that a negative multiparametric MRI might just be your ticket. Learn how MRI scans are reducing unnecessary biopsies and pinpointing significant prostate cancer with precision. keep reading

Multiparametric MRI (mpMRI) has proven itself as a powerful tool in detecting significant prostate cancer. By accurately identifying suspicious areas and distinguishing aggressive tumors from those that pose less risk, mpMRI is helping reduce unnecessary biopsies and providing clearer, more reliable diagnostic information for better treatment decisions. keep reading

Research shows that only three needles may be required for an accurate in-bore MRI-guided biopsy. This approach reduces patient discomfort, shortens procedure time, and maintains high diagnostic accuracy compared to traditional methods involving more needles. keep reading